Oxidative Stress Modulates Complement Factor H Expression in Retinal Pigmented Epithelial Cells by Acetylation of FOXO3

Zhihao Wu, Thomas Lauer, Anna Sick-Samuels, Sean F. Hackett, Peter A. Campochiaro

Journal of Biological Chemistry · 2007 · 117 citations · 40 references

DOIFull text

Open access

Concepts

Abstract

Age-related macular degeneration (AMD), the leading cause of severe vision loss in the elderly, is a complex disease that results from genetic modifications that increase susceptibility to environmental exposures. Smoking, a major source of oxidative stress, increases the incidence and severity of AMD, and antioxidants slow progression, suggesting that oxidative stress plays a major role. Polymorphisms in the complement factor H (CFH) gene that reduce activity of CFH increase the risk of AMD. In this study we demonstrate an interaction between these two risk factors, because oxidative stress reduces the ability of an inflammatory cytokine, interferon-γ, to increase CFH expression in retinal pigmented epithelial cells. The interferon-γ-induced increase in CFH is mediated by transcriptional activation by STAT1, and its suppression by oxidative stress is mediated by acetylation of FOXO3, which enhances FOXO3 binding to the CFH promoter, reduces its binding to STAT1, inhibits STAT1 interaction with the CFH promoter, and reduces expression of CFH. Expression of SIRT1, a mammalian homolog of NAD-dependent protein deacetylase sir2, attenuated FOXO3 recruitment to the CFH regulatory region and reversed the H2O2-induced repression of CFH gene expression. These data suggest an important interaction between environmental exposure and genetic susceptibility in the pathogenesis of AMD and, by elucidating molecular signaling involved in the interaction, provide potential targets for therapeutic intervention. Age-related macular degeneration (AMD), the leading cause of severe vision loss in the elderly, is a complex disease that results from genetic modifications that increase susceptibility to environmental exposures. Smoking, a major source of oxidative stress, increases the incidence and severity of AMD, and antioxidants slow progression, suggesting that oxidative stress plays a major role. Polymorphisms in the complement factor H (CFH) gene that reduce activity of CFH increase the risk of AMD. In this study we demonstrate an interaction between these two risk factors, because oxidative stress reduces the ability of an inflammatory cytokine, interferon-γ, to increase CFH expression in retinal pigmented epithelial cells. The interferon-γ-induced increase in CFH is mediated by transcriptional activation by STAT1, and its suppression by oxidative stress is mediated by acetylation of FOXO3, which enhances FOXO3 binding to the CFH promoter, reduces its binding to STAT1, inhibits STAT1 interaction with the CFH promoter, and reduces expression of CFH. Expression of SIRT1, a mammalian homolog of NAD-dependent protein deacetylase sir2, attenuated FOXO3 recruitment to the CFH regulatory region and reversed the H2O2-induced repression of CFH gene expression. These data suggest an important interaction between environmental exposure and genetic susceptibility in the pathogenesis of AMD and, by elucidating molecular signaling involved in the interaction, provide potential targets for therapeutic intervention. Age-related macular degeneration (AMD) 2The abbreviations used are: AMD, age-related macular degeneration; CFH, complement factor H; sir2, silent information regulator 2; IFN-γ, interferon-γ; RPE cells, retinal pigmented epithelial cells; STAT, signal transducers and activators of transcription; ChIP, chromatin immunoprecipitation; ANOVA, analysis of variance; JNK, Jun-N-terminal kinase. 2The abbreviations used are: AMD, age-related macular degeneration; CFH, complement factor H; sir2, silent information regulator 2; IFN-γ, interferon-γ; RPE cells, retinal pigmented epithelial cells; STAT, signal transducers and activators of transcription; ChIP, chromatin immunoprecipitation; ANOVA, analysis of variance; JNK, Jun-N-terminal kinase. is the most prevalent cause of severe vision loss in patients over the age of 60 in developed countries (1Klein R. Klein B.E. Linton K.L. Ophthalmology. 1992; 99: 933-943Abstract Full Text PDF PubMed Scopus (1600) Google Scholar, 2Mitchell P. Smith W. Attebo K. Wang J.J. Ophthalmology. 1995; 102: 1450-1460Abstract Full Text PDF PubMed Scopus (931) Google Scholar). It is a complex group of diseases in which genetic susceptibility combined with environmental exposures result in a disease phenotype that consists of deposits (drusen) along Bruch's membrane, atrophy of photoreceptors and retinal pigmented epithelial (RPE) cells (geographic atrophy), and enhanced risk of choroidal neovascularization. Several genetic susceptibility loci for AMD have been identified, but some variants in and around the complement factor H (CFH) gene are associated with particularly high risk, and others are associated with reduced risk (3Klein R.J. Zeiss C. Chew E.Y. Tsai J.Y. Sackler R.S. Haynes C. Henning A.K. SanGiovanni J.P. Mane S.M. Mayne S.T. Bracken M.B. Ferris F.L. Ott J. Barnstable C. Hoh J. Science. 2005; 308: 385-389Crossref PubMed Scopus (3434) Google Scholar, 4Edwards A.O. Ritter R.R. Abel K.J. Manning A. Panhuysen C. Farrer L.A. Science. 2005; 308: 421-424Crossref PubMed Scopus (2042) Google Scholar, 5Haines J.L. Hauser M.A. Schmidt S. Scott W.K. Olson L.M. Gallins P. Spencer K.L. Kwan S.Y. Noureddine M. Gilbert J.R. Schnetz-Boutaud N. Agarwal A. Postel E.A. Pericak-Vance M.A. Science. 2005; 308: 419-421Crossref PubMed Scopus (2033) Google Scholar, 6Rivera A. Fisher S.A. Fritsche L.G. Keilhauer C.N. Lichtner P. Meitinger T. Weber B.H. Hum. Mol. Genet. 2005; 14: 3227-3236Crossref PubMed Scopus (654) Google Scholar, 7Li M. Atmaca-Sonmez P. Othman M. Branham K.E.H. Khanna R. Wade M.S. Yun L. Liang L. Zereparsi S. Swaroop A. Abecasis G.R. Nat. Genet. 2006; 38: 1049-1054Crossref PubMed Scopus (286) Google Scholar). A polymorphism encoding the sequence variation Y402H is associated with increased risk (3Klein R.J. Zeiss C. Chew E.Y. Tsai J.Y. Sackler R.S. Haynes C. Henning A.K. SanGiovanni J.P. Mane S.M. Mayne S.T. Bracken M.B. Ferris F.L. Ott J. Barnstable C. Hoh J. Science. 2005; 308: 385-389Crossref PubMed Scopus (3434) Google Scholar, 4Edwards A.O. Ritter R.R. Abel K.J. Manning A. Panhuysen C. Farrer L.A. Science. 2005; 308: 421-424Crossref PubMed Scopus (2042) Google Scholar, 5Haines J.L. Hauser M.A. Schmidt S. Scott W.K. Olson L.M. Gallins P. Spencer K.L. Kwan S.Y. Noureddine M. Gilbert J.R. Schnetz-Boutaud N. Agarwal A. Postel E.A. Pericak-Vance M.A. Science. 2005; 308: 419-421Crossref PubMed Scopus (2033) Google Scholar, 6Rivera A. Fisher S.A. Fritsche L.G. Keilhauer C.N. Lichtner P. Meitinger T. Weber B.H. Hum. Mol. Genet. 2005; 14: 3227-3236Crossref PubMed Scopus (654) Google Scholar), and in vitro studies have shown that CFH His-402 has reduced binding to C-reactive protein, heparin, and RPE cells, which reduces its complement control activity (8Skerka C. Lauer N. Weinberger A.A.W.A. Keilhauer C.N. Suhnel J. Smith R. Schlotzer-Schrehardt U. Fritsche L. Heinen S. Hartmann A. Weber B.H.F. Zipfel P.F. Mol. Immunol. 2007; 44: 3398-3406Crossref PubMed Scopus (158) Google Scholar, 9Laine M. Jarva H. Seitsonen S. Haapasalo K. Lehtinen M.J. Lindeman N. Anderson D.H. Johnson P.T. Jarvela I. Jokiranta T.S. Hageman G.S. Immonen I. Meri S. J. Immunol. 2007; 178: 3831-3836Crossref PubMed Scopus (198) Google Scholar). In addition, detailed analysis of single nucleotide polymorphisms in and around the CFH gene has identified variants, some in noncoding regions, with high risk (7Li M. Atmaca-Sonmez P. Othman M. Branham K.E.H. Khanna R. Wade M.S. Yun L. Liang L. Zereparsi S. Swaroop A. Abecasis G.R. Nat. Genet. 2006; 38: 1049-1054Crossref PubMed Scopus (286) Google Scholar). No single polymorphism could account for the contribution of CFH, and instead, haplotypes associated with increased or decreased risk were identified. The authors hypothesized that these haplotypes might modulate risk of AMD not by disrupting protein function but, rather, by altering expression. Therefore, either reducing the amount of CFH or reducing its complement-modulating activity may increase the risk of AMD. High risk and protective variants have also been identified in other genes that code for proteins involved in the regulation of complement, complement factor B, and complement component 2 (10Gold B. Merriam J.E. Zernant J. Hancox L.S. Taiber A.J. Gehrs K. Cramer K. Neel J. Bergeron J. Barile G.R. Smith R.T. Hageman G.S. Dean M. Allikmets R. Nat. Genet. 2006; 38: 458-462Crossref PubMed Scopus (919) Google Scholar). This supports the hypothesis that dysregulation of complement activity contributes to the development of AMD. The strongest environmental risk factor for AMD is cigarette smoking, which is associated with substantially higher incidences of geographic atrophy and choroidal neovascularization (11Smith W. Assink J. Klein R. Mitchell P. Klaver C.C. Klein B.E. Hofman A. Jensen S. Wang J.J. de Jong P.T. Ophthalmology. 2001; 108: 697-704Abstract Full Text Full Text PDF PubMed Scopus (805) Google Scholar, 12Khan J.C. Thurlby D.A. Shahid H. Clayton D.G. Yates J.R. Bradley M. Moore A.T. Bird A.C. Br. J. Ophthalmol. 2006; 90: 75-80Crossref PubMed Scopus (292) Google Scholar). The mechanism by which smoking increases the incidence and severity of AMD is uncertain, but cigarette smoke is known to contain numerous oxidants (13Smith C.J. Hansch C. Food Chem. Toxicol. 2000; 38: 637-646Crossref PubMed Scopus (187) Google Scholar). Exposure of mice to cigarette smoke or hydroquinone, an oxidant known to be present in cigarette smoke, resulted in sub-RPE deposits and diffuse thickening of Bruch's membrane (14Espinosa-Heidmann D.G. Suner I.J. Catanuto P. Hernandez E.P. Marin-Castano M.E. Cousins S.W. Investig. Ophthalmol. Vis. Sci. 2006; 47: 729-737Crossref PubMed Scopus (153) Google Scholar), suggesting that oxidative stress is capable of promoting these phenotypic characteristics of AMD. Oxidative stress has also been implicated in AMD by the Age-Related Eye Disease Study, which showed that antioxidants and zinc reduce the risk of individuals with large drusen progressing to advanced AMD, defined as choroidal neovascularization or severe geographic atrophy involving the center of the fovea (15The Age-related Eye Disease Study Research GroupArch. Ophthalmol. 2001; 119: 1417-1436Crossref PubMed Scopus (2521) Google Scholar). Also, proteomic analysis has demonstrated that drusen contain numerous proteins with adducts that are commonly caused by oxidative damage (16Crabb J.W. Miyagi M. Gu X. Shadrach K. West K. Sakaguchi H. Kamei M. Hasan A. Yan L. Rayborn M.E. Salomon R.G. Hollyfield J.G. Proc. Natl. Acad. Sci. U. S. A. 2002; 99: 14682-14687Crossref PubMed Scopus (961) Google Scholar). Thus, genetic studies suggest that the level of expression of CFH may play a role in the pathogenesis of AMD and several other lines of evidence implicate oxidative stress. In this study we sought to test the hypothesis that oxidative stress influences the expression of CFH. Reagents, Cells, and Transfections—Interferon-γ (IFN-γ) was obtained from Abcam (Cambridge, MA). The inhibitors PD98059, LY294002, p38 inhibitor, and PP2 were purchased from Calbiochem and used at concentrations of 50, 20, 10, and 5 μm, respectively. These concentrations were found to be effective in previous studies (17Ceryak S. Zingarello C. O'Brien T. Patierno S.R. Mol. Cell. Biochem. PubMed Scopus Google Scholar, H. S. T. S. A. J. Chem. 2005; Full Text Full Text PDF PubMed Scopus Google Scholar, J.W. N. Acad. Sci. PubMed Scopus Google Scholar, J.Y. J. Cell. Biochem. PubMed Scopus Google Scholar). CFH was obtained from and were obtained from MA). was obtained from RPE cells L.M. Eye PubMed Scopus Google were in with cells were in and with to the CFH were by as and the in The were the and of The and were by of for Research for MA). The was by of MA). and were by used for to to to to to protein to in a cells were in and were in the amount of protein was to a of a and by The proteins were to a membrane binding was by with at for 2 with at A of and a of other was The proteins were by West were by a and cells were and was the and with to of was at for 2 of of of of of of and of was the The to CFH were to in two or at to of The were at for at for 5 and at for for a of was a single and The for was a with of known A of the large of protein was to provide an cells were in and were at CFH in with control were along with FOXO3 cells cells in the were with and for 5 and with cells were with for the of and activity was the with a to the were to for cells were and the at were with and for were with and in of deacetylase inhibitors and inhibitors and inhibitors and The were with for 5 by the of protein for The were with and with The proteins were from the by in for 5 and by with were as by K. Nat. 2006; PubMed Scopus Google with cells were with and for in and with at for by the of to a of and for 5 2 with cells were in of and by The was in of 5 and deacetylase inhibitors and inhibitors and inhibitors and The was in and for of at and West was by the from chromatin and an to that that was The was by and was as an of was used for with or the of of in an for at The were with protein and with was from control by the of The and were by with of with or and for to the The was by the by was with the to with a High the of was a in the FOXO3 binding were by by The two were A and and and are as the and were by analysis of with for with Oxidative of function of CFH is to the complement to damage P.F. 2001; PubMed Scopus Google Scholar). The expression of CFH is increased by the inflammatory cytokine, Immunol. PubMed Scopus Google Scholar). The is the major source of CFH, but the RPE is a source of in the R. Investig. Ophthalmol. Vis. Sci. 2006; 47: PubMed Scopus Google Scholar). of RPE cells with increased expression of CFH with a with Exposure of RPE cells to or reduced the of CFH with a and some of from but the of CFH in as in This of is to oxidative stress because is in a by with the and with this and two other of oxidative stress, and at concentrations shown not to reduce over this L. A. H. J. Cell. 2006; PubMed Scopus Google Scholar), reduced CFH in RPE cells This could be to of the or in its between these we the of oxidative stress CFH activity a The of CFH activity was reduced by H2O2-induced oxidative stress STAT1 of CFH is a factor that of Nat. Immunol. 2006; PubMed Scopus Google Scholar). STAT1 the in RPE cells, were to cells with increased of STAT1 or STAT1 showed enhanced of and this was decreased in cells STAT1 in the of IFN-γ, RPE cells STAT1 substantially CFH cells STAT1 This that STAT1 plays an important role in of CFH in RPE cells. Oxidative of Jun-N-terminal and of the of RPE of STAT1, which to the and that oxidative stress reduces of STAT1 and from of CFH in RPE cells. test this we with an that increased in RPE cells, and this was not reduced by with the increase was increased by is an important component of several signaling inhibitors were used to activation of or protein was involved in oxidative of CFH expression. In to the protein inhibitors (17Ceryak S. Zingarello C. O'Brien T. Patierno S.R. Mol. Cell. Biochem. PubMed Scopus Google and p38 J.W. N. Acad. Sci. PubMed Scopus Google and the PP2 J.Y. J. Cell. Biochem. PubMed Scopus Google Scholar), which the H. S. T. S. A. J. Chem. 2005; Full Text Full Text PDF PubMed Scopus Google caused of expression of CFH with also caused in CFH and the of caused a suggesting an is a for the signaling of the of are targets of the L. Hernandez R. PubMed Scopus Google Scholar, S. R. J. Chem. 2000; Full Text Full Text PDF PubMed Scopus Google Scholar). In have been identified and implicated in as and of S. R. J. Chem. 2000; Full Text Full Text PDF PubMed Scopus Google Scholar). The of CFH expression caused to for of of proteins in enhanced activity of the results in of proteins and gene expression H. A. T. T. U. J. Biochem. 2005; PubMed Scopus Google Scholar). oxidative stress could the of by RPE cells with a protein showed diffuse in the of with IFN-γ, a of the the in to oxidative stress, was we that not activation of we that the of to the by was not mediated by in the of In some oxidative stress has been shown to increase and transcriptional activity activation of M.A. S. de I. de J.L. J. PubMed Scopus Google Scholar). and proteins but at which is by factors, proteins at that from the JNK, which is by oxidative stress or other of stress, proteins at that to the and and are the of which oxidative stress the of M.A. S. de I. de J.L. J. PubMed Scopus Google Scholar, J. N. J. 2005; PubMed Scopus Google Scholar). This to be the in RPE cells because with caused activation of in the and of or and as we expression of CFH was reduced by in the or of with the that oxidative stress the of FOXO3 the H2O2-induced in CFH Expression in RPE of the sequence of the region of the in the CFH gene showed a FOXO3 binding in to a STAT1 binding FOXO3 was in RPE cells by with or of a FOXO3 expression for CFH showed that FOXO3 reduced of CFH in cells in a and the was enhanced by The of FOXO3 that is by oxidative stress Wang X. L. K. B. Mol. Cell. 2005; PubMed Scopus Google Scholar), was also reduced in in RPE cells with a FOXO3 that the for A. P. H. R. L.S. D.A. M.E. Science. PubMed Scopus Google caused a in CFH In with a with a in the binding A. P. H. R. L.S. D.A. M.E. Science. PubMed Scopus Google caused in of CFH, that binding of FOXO3 to is for its of CFH expression. Expression of the the ability of to reduce CFH, but not suggesting that FOXO3 is to be the factor for of CFH by oxidative stress. In with these CFH activity was reduced in RPE cells FOXO3 FOXO3 to the regulatory region the FOXO3 binding the CFH promoter, were in RPE cells to FOXO3 the region the FOXO3 binding and cells with and showed increased recruitment of FOXO3 to the CFH of FOXO3 to the is in the of and and this may be of the of are for binding of FOXO3 to the CFH the role of the FOXO3 binding in of CFH were in the to or to to the which the FOXO3 and STAT1 binding showed of of CFH activity by A to the FOXO3 and STAT1 binding A to the STAT1, but not the FOXO3 showed of activity by that was not reduced by A with in the FOXO3 binding to also showed a increase in activity in the of that was not reduced by with that FOXO3 mediated the H2O2-induced repression of CFH Oxidative of FOXO3 and of STAT1 to the CFH the binding of FOXO3 and STAT1 to the CFH promoter, was or control with that a of the CFH showed a increase in CFH by from chromatin of RPE cells with and with either that the of FOXO3 with CFH is increased in RPE cells to oxidative stress In with showed enhanced binding of STAT1 to CFH in RPE cells with that was reduced by with and that the of FOXO3 with CFH of oxidative stress reduces binding of STAT1 to its in the CFH of RPE with by with showed increased of FOXO3 with STAT1 in cells that was reduced in cells with and with cells, FOXO3 showed a increase in STAT1 activity in the of IFN-γ, and this was reduced by These data suggest that in to FOXO3 to STAT1 its binding the CFH and may CFH but in the of oxidative stress, FOXO3 to the CFH promoter, reduces STAT1 binding to the promoter, and reduces expression of CFH. This that oxidative stress a of FOXO3 that its in a that its for binding is enhanced and its for binding STAT1 is a FOXO3 by Oxidative Expression of and of proteins mechanism for regulation of transcriptional of RPE with by with an that showed that oxidative stress the acetylation of FOXO3 a and is a mammalian homolog of the NAD-dependent protein deacetylase sir2, which has been to control FOXO3 function by A. P. H. R. L.S. D.A. M.E. Science. PubMed Scopus Google Scholar, N. M. C. Gu W. M. L. Cell. Full Text Full Text PDF PubMed Scopus Google Scholar, A. L.G. de L.M. J. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar). Oxidative stress to reduce the increase in CFH in RPE cells SIRT1, but cells a deacetylase activity the deacetylase which the of FOXO3 in the of oxidative stress, attenuated expression of CFH the mechanism of the of CFH we the ability of STAT1 and FOXO3 to to the CFH in RPE cells showed that with to increased recruitment of STAT1 to the CFH and reduced FOXO3 binding These data suggest that the acetylation of FOXO3 is in CFH and the of is to increased recruitment of the STAT1 and decreased of the FOXO3 in the CFH studies a that oxidative stress contributes to the pathogenesis of AMD and this to Age-Related Eye Disease Study, which (15The Age-related Eye Disease Study Research GroupArch. Ophthalmol. 2001; 119: 1417-1436Crossref PubMed Scopus (2521) Google Scholar). The that a amount of genetic susceptibility is by variants in the CFH which a protein that the complement and has known role in from oxidative stress, to in a The mechanism by which CFH variants risk of AMD is but that is to the ability of CFH to complement activity and not some because variants in factor or complement component other of complement also the risk for development of AMD (10Gold B. Merriam J.E. Zernant J. Hancox L.S. Taiber A.J. Gehrs K. Cramer K. Neel J. Bergeron J. Barile G.R. Smith R.T. Hageman G.S. Dean M. Allikmets R. Nat. Genet. 2006; 38: 458-462Crossref PubMed Scopus (919) Google Scholar). It is that membrane is to damage from and is by in activity of CFH. This is to the in the because activation of the complement to CFH results in M. L. A. P. P. Full Text PDF PubMed Scopus Google Scholar, K. J. M. J. Investig. 1995; PubMed Scopus Google Scholar, J. J. M.J. M. Nat. Genet. 2002; PubMed Scopus Google Scholar). The of membrane and the to complement activation is by the of in AMD, in patients with Hageman J.C. M. M. L. Meri S. S. Smith R.J. W. P. M. R. Zipfel P.F. J. 2005; PubMed Scopus Google Scholar). CFH plays a protective role for membrane, a source of be A previous study has shown and protein for CFH in the which the of membrane, and several other in the R. Investig. Ophthalmol. Vis. Sci. 2006; 47: PubMed Scopus Google Scholar). In this we have that RPE cells CFH, and as is the in epithelial cells M. L.A. PubMed Scopus Google Scholar), expression of CFH in RPE cells is by the inflammatory cytokine, have identified a between the two major risk for AMD, because oxidative stress reduces expression of CFH in RPE cells. The mechanism of this suppression the STAT1 and the are mammalian factors, FOXO3 and are by signaling and are in the by the which as a transcriptional L. Hernandez R. PubMed Scopus Google Scholar, N. S. W. S. J. Proc. Natl. Acad. Sci. U. S. A. 2000; PubMed Scopus Google Scholar). The are in the in by and to the is oxidative stress is in which are in a by JNK, which the M.A. S. de I. de J.L. J. PubMed Scopus Google Scholar, J. N. J. 2005; PubMed Scopus Google Scholar). In the binding and proteins as Biochem. J. PubMed Scopus Google Scholar). is a of a of that are of information regulator which increases in and but the of to S. M. L. 2000; PubMed Scopus Google Scholar). is the mammalian most to a of proteins and the A. P. H. R. L.S. D.A. M.E. Science. PubMed Scopus Google Scholar, N. M. C. Gu W. M. L. Cell. Full Text Full Text PDF PubMed Scopus Google Scholar, A. L.G. de L.M. J. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar, J. S. A. L. Gu W. Cell. 2001; Full Text Full Text PDF PubMed Scopus Google Scholar). have the ability to of several genes genes involved in from oxidative stress and and and these be either or by the and K. T. K. N. J. Chem. 2002; Full Text Full Text PDF PubMed Scopus Google Scholar, Biochem. PubMed Google Scholar, H. P. Nat. 2005; PubMed Scopus Google Scholar). In this study we found that in RPE cells, FOXO3 is in the with some FOXO3 to the STAT1 its binding the CFH and not activation of the by in the of oxidative stress, is of FOXO3, and is which reduces its interaction with STAT1, increases its binding to the CFH promoter, STAT1 of its binding and reduces expression of CFH The previous suggesting that proteins may function as either transcriptional activators or Biochem. PubMed Google Scholar, H. P. Nat. 2005; PubMed Scopus Google Scholar). The of the molecular mechanism of the suppression of expression of CFH by oxidative stress targets for therapeutic intervention. of inhibitors could to the oxidative suppression of CFH expression in RPE cells. increased expression of by gene the could in patients at risk for or of AMD at of oxidative stress with suppression of acetylation of FOXO3, and of other inhibitors of complement of at of for with the CFH analysis and of at for with

References

40